Dudediligence.

Roivant Sciences Ltd

ROIVNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$261.5M

31 notices · 8,849,159 sh

Dec 2025 to Oct 2026

Reported ·

$648.3M

81 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

18 of 81 reported sales carry the 10b5-1 box. Together they are 3.90% of the shares on issue.

PLANNED · FORM 144Dec 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-30: Venker Eric, Form 1442026-09-15: MELISSA EPPERLY, Form 1442026-09-15: MEGHAN FITZGERALD, Form 1442026-09-08: MEGHAN FITZGERALD, Form 1442026-08-28: Venker Eric, Form 1442026-08-21: MAYUKH SUKHATME, Form 1442026-08-20: MAYUKH SUKHATME, Form 1442026-08-19: MAYUKH SUKHATME, Form 1442026-08-18: MAYUKH SUKHATME, Form 1442026-08-17: MAYUKH SUKHATME, Form 1442026-08-14: MAYUKH SUKHATME, Form 1442026-07-27: Venker Eric, Form 1442026-06-30: MEGHAN FITZGERALD, Form 1442026-06-30: KEITH S MANCHESTER, Form 1442026-06-29: MELISSA EPPERLY, Form 1442026-06-26: MAYUKH SUKHATME, Form 1442026-06-25: MAYUKH SUKHATME, Form 1442026-06-24: Venker Eric, Form 1442026-05-22: Venker Eric, Form 1442026-04-20: Venker Eric, Form 1442026-04-16: Gline Matthew, Form 1442026-04-08: JENNIFER HUMES, Form 1442026-03-26: MEGHAN FITZGERALD, Form 1442026-03-17: Venker Eric, Form 1442026-03-16: MELISSA B EPPERLY, Form 1442026-02-20: FRANK TORTI, Form 1442026-02-19: FRANK TORTI, Form 1442026-02-13: Venker Eric, Form 1442026-02-09: Sukhatme Mayukh, Form 1442026-01-12: Venker Eric, Form 1442025-12-31: Sukhatme Mayukh, Form 1442025-10-06: Venker Eric, sold2025-10-09: Venker Eric, sold2025-10-15: Venker Eric, sold2025-11-07: Venker Eric, sold2025-11-13: Ramaswamy Vivek, sold2025-11-19: QVT Financial LP, sold2025-11-19: Gold Daniel Allen, sold2025-11-19: MANCHESTER KEITH S, sold2025-12-09: Venker Eric, sold2025-12-11: Ramaswamy Vivek, sold2025-12-15: Gline Matthew, sold2025-12-16: QVT Financial LP, sold2025-12-16: MANCHESTER KEITH S, sold2025-12-16: Gold Daniel Allen, sold2025-12-17: Sukhatme Mayukh, sold2025-12-23: Venker Eric, sold2025-12-23: Pulik Richard, sold2025-12-29: Sukhatme Mayukh, sold2026-01-12: Venker Eric, sold2026-02-09: Sukhatme Mayukh, sold2026-02-11: QVT Financial LP, sold2026-02-11: Gold Daniel Allen, sold2026-02-11: MANCHESTER KEITH S, sold2026-02-13: Venker Eric, sold2026-02-19: Torti Frank, sold2026-03-16: Epperly Melissa B,, sold2026-03-17: Venker Eric, sold2026-03-26: Fitzgerald Meghan, sold2026-04-08: Humes Jennifer, sold2026-04-16: Gline Matthew, sold2026-04-20: Venker Eric, sold2026-05-22: Venker Eric, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-30Venker Eric, President & Immunovant CEO$7,323,556
200,000 shplan 2025-03-28Form 4s on file end Jun 23144 ↗
2026-09-15MELISSA EPPERLY, Director$930,662
22,688 shplan 2026-03-30Form 4s on file end Jun 23144 ↗
2026-09-15MEGHAN FITZGERALD, Officer$209,694
5,112 shplan 2026-03-30Form 4s on file end Jun 23144 ↗
2026-09-08MEGHAN FITZGERALD, Director$698,600
20,000 shplan 2026-03-30Form 4s on file end Jun 23144 ↗
2026-08-28Venker Eric, President & Immunovant CEO$7,147,088
200,000 shplan 2025-03-28Form 4s on file end Jun 23144 ↗
2026-08-21MAYUKH SUKHATME, President & CIO$5,280,004
144,756 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-20MAYUKH SUKHATME, President & CIO$653,408
17,519 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-19MAYUKH SUKHATME, President & CIO$6,426,357
172,899 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-18MAYUKH SUKHATME, President & CIO$5,029,209
136,942 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-17MAYUKH SUKHATME, President & CIO$10.3M
284,707 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-14MAYUKH SUKHATME, President & CIO$8,809,768
243,177 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-27Venker Eric, President & Immunovant CEO$6,989,924
200,000 shplan 2025-03-28Form 4s on file end Jun 23144 ↗
2026-06-30MEGHAN FITZGERALD, Director$347,300
10,000 shplan 2026-03-30Form 4s on file end Jun 23144 ↗
2026-06-30KEITH S MANCHESTER, Director$7,090,280
200,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-29MELISSA EPPERLY, Director$604,743
17,750 shplan 2026-03-30Form 4s on file end Jun 23144 ↗
2026-06-26MAYUKH SUKHATME, President & CIO$17.0M
500,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-25MAYUKH SUKHATME, President & CIO$17.1M
500,000 shno plan date144 ↗
Form 4, 2026-06-29: sold 1,000,000 at $34.10 Form 4 ↗
2026-06-24Venker Eric, President & Immunovant CEO$6,631,659
200,000 shplan 2025-03-28144 ↗
Form 4, 2026-06-26: sold 200,000 at $33.16 Form 4 ↗
2026-05-22Venker Eric, President & Immunovant CEO$6,054,731
200,000 shplan 2025-03-28144 ↗
Form 4, 2026-05-22: sold 200,000 at $30.27 Form 4 ↗
2026-04-20Venker Eric, President & Immunovant CEO$5,917,135
200,000 shplan 2025-03-28144 ↗
Form 4, 2026-04-22: sold 200,000 at $29.59 Form 4 ↗
2026-04-16Gline Matthew, CEO$8,449,876
289,774 shno plan date144 ↗
Form 4, 2026-04-20: sold 289,774 at $29.16 Form 4 ↗
2026-04-08JENNIFER HUMES, Chief Accounting Officer$384,035
13,538 shno plan date144 ↗
Form 4, 2026-04-10: sold 13,538 at $28.37 Form 4 ↗
2026-03-26MEGHAN FITZGERALD, Director$1,921,458
70,000 shno plan date144 ↗
Form 4, 2026-03-30: sold 70,000 at $27.45 Form 4 ↗
2026-03-17Venker Eric, President & Immunovant CEO$5,648,836
200,000 shplan 2025-03-28144 ↗
Form 4, 2026-03-19: sold 200,000 at $28.24 Form 4 ↗
2026-03-16MELISSA B EPPERLY, Director$1,200,498
41,861 shno plan date144 ↗
Form 4, 2026-03-18: sold 41,861 at $28.68 Form 4 ↗
2026-02-20FRANK TORTI, President and Vant Chair$44.0M
1,600,000 shplan 2025-11-20no Form 4 on file144 ↗
2026-02-19FRANK TORTI, President and Vant Chair$38.5M
1,400,000 shplan 2025-11-20144 ↗
Form 4, 2026-02-23: sold 3,000,000 at $27.35 Form 4 ↗
2026-02-13Venker Eric, President & Immunovant CEO$5,298,373
200,000 shplan 2025-03-28144 ↗
Form 4, 2026-02-18: sold 200,000 at $26.49 Form 4 ↗
2026-02-09Sukhatme Mayukh, President & CIO$8,985,276
339,441 shno plan date144 ↗
Form 4, 2026-02-11: sold 339,441 at $26.47 Form 4 ↗
2026-01-12Venker Eric, President & Immunovant CEO$4,383,694
200,000 shplan 2025-03-28144 ↗
Form 4, 2026-01-14: sold 200,000 at $21.92 Form 4 ↗
2025-12-31Sukhatme Mayukh, President & CIO$22.1M
1,018,995 shno plan date144 ↗
Form 4, 2025-12-31: sold 1,330,868 at $21.72 Form 4 ↗